Functional and pharmacological MRI in understanding brain function at a systems level.

Functional magnetic resonance imaging (fMRI) methods have been extensively applied to study the human brain and its functional organization in healthy and disease states. A strong rationale exists for the extension of this approach to animal models as a translational tool to bridge clinical and preclinical research. Specifically, the development of pharmacological MRI (phMRI), i.e., the use of fMRI to map spatiotemporal patterns of brain activity induced by pharmacological agents, has provided a robust and flexible tool to resolve brain circuits and mechanism-specific functional changes produced by selective intervention in different neurotransmitter systems in vivo. This chapter describes the methodological aspects of fMRI and phMRI in preclinical species, and some of the key findings, with a special emphasis on the translational potential of these methods in neuropharmacological research.

[1]  Stephen M. Smith,et al.  Investigations into resting-state connectivity using independent component analysis , 2005, Philosophical Transactions of the Royal Society B: Biological Sciences.

[2]  H. Holcomb,et al.  Probing the human hippocampus using rCBF: Contrasts in schizophrenia , 2001, Hippocampus.

[3]  John Suckling,et al.  Brain Imaging Correlates of Depressive Symptom Severity and Predictors of Symptom Improvement After Antidepressant Treatment , 2007, Biological Psychiatry.

[4]  Govind Nair,et al.  The Neural Consequences of Repeated Cocaine Exposure Revealed by Functional MRI in Awake Rats , 2005, Neuropsychopharmacology.

[5]  A. Carlsson,et al.  Neurotransmitter interactions in schizophrenia—therapeutic implications , 1999, Biological Psychiatry.

[6]  Adam M. Brickman,et al.  Volume of the cingulate and outcome in schizophrenia , 2005, Schizophrenia Research.

[7]  J. Krystal,et al.  Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists. , 2000, Archives of general psychiatry.

[8]  Afonso C. Silva,et al.  Elevated endogenous GABA level correlates with decreased fMRI signals in the rat brain during acute inhibition of GABA transaminase , 2005, Journal of neuroscience research.

[9]  H. Meltzer Pre-clinical Pharmacology of Atypical Antipsychotic Drugs: A Selective Review , 1996, British Journal of Psychiatry.

[10]  W. R. Adey,et al.  Computer techniques in correlation and spectral analyses of cerebral slow waves during discriminative behavior. , 1961, Experimental neurology.

[11]  Timothy Q. Duong,et al.  Imaging cocaine-induced changes in the mesocorticolimbic dopaminergic system of conscious rats , 2004, Journal of Neuroscience Methods.

[12]  J. Lieberman,et al.  Mechanisms of typical and atypical antipsychotic drug action in relation to dopamine and NMDA receptor hypofunction hypotheses of schizophrenia , 1999, Molecular Psychiatry.

[13]  Karl J. Friston Analysing brain images: principles and overview , 1997 .

[14]  M. Posner,et al.  Localization of cognitive operations in the human brain. , 1988, Science.

[15]  Ji-Kyung Choi,et al.  Mapping interactions between dopamine and adenosine A2a receptors using pharmacologic MRI , 2005, Synapse.

[16]  M. Picciotto Nicotine as a modulator of behavior: beyond the inverted U. , 2003, Trends in pharmacological sciences.

[17]  M. Besson,et al.  Inducibility of c‐Fos protein in visuo‐motor system and limbic structures after acute and repeated administration of nicotine in the rat , 1998, Synapse.

[18]  Angelo Bifone,et al.  Functional magnetic resonance mapping of intracerebroventricular infusion of a neuroactive peptide in the anaesthetised rat , 2005, Journal of Neuroscience Methods.

[19]  Justin L. Vincent,et al.  Intrinsic functional architecture in the anaesthetized monkey brain , 2007, Nature.

[20]  Edward T. Bullmore,et al.  Efficiency and Cost of Economical Brain Functional Networks , 2007, PLoS Comput. Biol..

[21]  S Makeig,et al.  Analysis of fMRI data by blind separation into independent spatial components , 1998, Human brain mapping.

[22]  Angelo Bifone,et al.  Community structure and modularity in networks of correlated brain activity. , 2007, Magnetic resonance imaging.

[23]  S. Mosolov,et al.  Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial , 2007, Nature Medicine.

[24]  Angelo Bifone,et al.  In vivo mapping of functional connectivity in neurotransmitter systems using pharmacological MRI , 2007, NeuroImage.

[25]  Shane McKie,et al.  Glutamate and the neural basis of the subjective effects of ketamine: a pharmaco-magnetic resonance imaging study. , 2008, Archives of general psychiatry.

[26]  J. Fujimoto Chapter 49 – Laboratory Animal Anesthesia , 2002 .

[27]  Chunshui Yu,et al.  Altered resting-state functional connectivity and anatomical connectivity of hippocampus in schizophrenia , 2008, Schizophrenia Research.

[28]  Barry Horwitz,et al.  The pattern of functional coupling of brain regions in the awake rat , 1986, Brain Research.

[29]  J. Krystal,et al.  Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. , 1994, Archives of general psychiatry.

[30]  Stephen M. Smith,et al.  Probabilistic independent component analysis for functional magnetic resonance imaging , 2004, IEEE Transactions on Medical Imaging.

[31]  B. Morris,et al.  PCP: from pharmacology to modelling schizophrenia. , 2005, Current opinion in pharmacology.

[32]  G. Edelman,et al.  A measure for brain complexity: relating functional segregation and integration in the nervous system. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[33]  G Pfurtscheller,et al.  Event-Related changes of band power and coherence: methodology and interpretation. , 1999, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.

[34]  Edward T. Bullmore,et al.  Age-related changes in modular organization of human brain functional networks , 2009, NeuroImage.

[35]  G. Breese,et al.  Metabolic mapping of the rat brain after subanesthetic doses of ketamine: potential relevance to schizophrenia , 1998, Brain Research.

[36]  J. Bodurka,et al.  Heroin‐induced neuronal activation in rat brain assessed by functional MRI , 2000, Neuroreport.

[37]  Angelo Bifone,et al.  Pharmacological stimulation of NMDA receptors via co-agonist site suppresses fMRI response to phencyclidine in the rat , 2008, Psychopharmacology.

[38]  Angelo Bifone,et al.  A multimodality investigation of cerebral haemodynamics and autoregulation in phMRI , 2006 .

[39]  N. Farber The NMDA Receptor Hypofunction Model of Psychosis , 2003, Annals of the New York Academy of Sciences.

[40]  J. Frahm,et al.  Dynamic MR imaging of human brain oxygenation during rest and photic stimulation , 1992, Journal of magnetic resonance imaging : JMRI.

[41]  M. James,et al.  Pharmacological magnetic resonance imaging: a new application for functional MRI. , 2000, Trends in pharmacological sciences.

[42]  E. Bullmore,et al.  A Resilient, Low-Frequency, Small-World Human Brain Functional Network with Highly Connected Association Cortical Hubs , 2006, The Journal of Neuroscience.

[43]  J. Lurito,et al.  Multiple sclerosis: low-frequency temporal blood oxygen level-dependent fluctuations indicate reduced functional connectivity initial results. , 2002, Radiology.

[44]  P. Liddle,et al.  Immediate and delayed effects of risperidone on cerebral metabolism in neuroleptic naïve schizophrenic patients: correlations with symptom change , 2002, Journal of neurology, neurosurgery, and psychiatry.

[45]  Joseph B. Mandeville,et al.  Pharmacologic Magnetic Resonance Imaging (phMRI) , 2002 .

[46]  John C Gore,et al.  Assessing functional connectivity in the human brain by fMRI. , 2007, Magnetic resonance imaging.

[47]  O. Tervonen,et al.  Midazolam sedation increases fluctuation and synchrony of the resting brain BOLD signal. , 2005, Magnetic resonance imaging.

[48]  A. L. Dixon,et al.  Dopamine antagonist modulation of amphetamine response as detected using pharmacological MRI , 2005, Neuropharmacology.

[49]  T. Robbins,et al.  Neural systems of reinforcement for drug addiction: from actions to habits to compulsion , 2005, Nature Neuroscience.

[50]  Karl J. Friston,et al.  Images of the future: a philosophical coda , 1997 .

[51]  Bruce R. Rosen,et al.  Spatio-temporal characteristics of low-frequency BOLD signal fluctuations in isoflurane-anesthetized rat brain , 2008, NeuroImage.

[52]  M. Mintun,et al.  Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: an fMRI study , 2001, Biological Psychiatry.

[53]  Shane McKie,et al.  5‐HT2C antagonism blocks blood oxygen level‐dependent pharmacological‐challenge magnetic resonance imaging signal in rat brain areas related to feeding , 2008, The European journal of neuroscience.

[54]  C. Gross,et al.  Suppression of conditioning to ambiguous cues by pharmacogenetic inhibition of the dentate gyrus , 2007, Nature Neuroscience.

[55]  B. Kolb,et al.  Do rats have a prefrontal cortex? , 2003, Behavioural Brain Research.

[56]  S. McGaraughty,et al.  Mapping brain activity following administration of a nicotinic acetylcholine receptor agonist, ABT-594, using functional magnetic resonance imaging in awake rats , 2006, Neuroscience.

[57]  Joseph E LeDoux The Emotional Brain, Fear, and the Amygdala , 2003, Cellular and Molecular Neurobiology.

[58]  M E J Newman,et al.  Modularity and community structure in networks. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[59]  Angelo Bifone,et al.  Functional connectivity in the pharmacologically activated brain: Resolving networks of correlated responses to d‐amphetamine , 2007, Magnetic resonance in medicine.

[60]  Bita Moghaddam,et al.  Activation of metabotropic glutamate 2/3 receptors reverses the effects of NMDA receptor hypofunction on prefrontal cortex unit activity in awake rats. , 2005, Journal of neurophysiology.

[61]  Angelo Bifone,et al.  Pharmacological modulation of functional connectivity: the correlation structure underlying the phMRI response to d-amphetamine modified by selective dopamine D3 receptor antagonist SB277011A. , 2007, Magnetic resonance imaging.

[62]  B Horwitz,et al.  Intercorrelations of Glucose Metabolic Rates between Brain Regions: Application to Healthy Males in a State of Reduced Sensory Input , 1984, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[63]  A. Luria The Working Brain , 1973 .

[64]  D. Perkel,et al.  Simultaneously Recorded Trains of Action Potentials: Analysis and Functional Interpretation , 1969, Science.

[65]  M. Boly,et al.  Functional connectivity in the default network during resting state is preserved in a vegetative but not in a brain dead patient , 2009, Human brain mapping.

[66]  R G Hoffmann,et al.  Nicotine-induced limbic cortical activation in the human brain: a functional MRI study. , 1998, The American journal of psychiatry.

[67]  A. Blamire,et al.  Region‐specific effects of a tyrosine‐free amino acid mixture on amphetamine‐induced changes in BOLD fMRI signal in the rat brain , 2007, Synapse.

[68]  Angelo Bifone,et al.  Drug-anaesthetic interaction in phMRI: the case of the psychotomimetic agent phencyclidine. , 2008, Magnetic resonance imaging.

[69]  B R Rosen,et al.  Detection of dopaminergic neurotransmitter activity using pharmacologic MRI: Correlation with PET, microdialysis, and behavioral data , 1997, Magnetic resonance in medicine.

[70]  G. Aston-Jones,et al.  Locus coeruleus neurons in monkey are selectively activated by attended cues in a vigilance task , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[71]  E. Levin Nicotinic receptor subtypes and cognitive function. , 2002, Journal of neurobiology.

[72]  Jeffrey A Lieberman,et al.  Effects of Ketamine, MK-801, and Amphetamine on Regional Brain 2-Deoxyglucose Uptake in Freely Moving Mice , 2000, Neuropsychopharmacology.

[73]  G. Koob,et al.  Drug Addiction, Dysregulation of Reward, and Allostasis , 2001, Neuropsychopharmacology.

[74]  Karl J. Friston,et al.  Analysis of functional MRI time‐series , 1994, Human Brain Mapping.

[75]  C. Porro,et al.  Ketamine Effects on Local Cerebral Blood Flow and Metabolism in the Rat , 1987, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[76]  Angelo Bifone,et al.  Community structure in networks of functional connectivity: Resolving functional organization in the rat brain with pharmacological MRI , 2009, NeuroImage.

[77]  H. Möller,et al.  Hypermetabolic pattern in frontal cortex and other brain regions in unmedicated schizophrenia patients , 2005, European Archives of Psychiatry and Clinical Neuroscience.

[78]  Timothy Edward John Behrens,et al.  New approaches for exploring anatomical and functional connectivity in the human brain , 2004, Biological Psychiatry.

[79]  M. C. Angulo,et al.  Neuron-to-astrocyte signaling is central to the dynamic control of brain microcirculation , 2003, Nature Neuroscience.

[80]  S. Stahl Mechanism of action of serotonin selective reuptake inhibitors. Serotonin receptors and pathways mediate therapeutic effects and side effects. , 1998, Journal of affective disorders.

[81]  Edward D Levin,et al.  Cognitive effects of nicotine , 2001, Biological Psychiatry.

[82]  D. Tank,et al.  Brain magnetic resonance imaging with contrast dependent on blood oxygenation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[83]  F. Crespi,et al.  Selective D3 Receptor Antagonist SB-277011-A Potentiates the Effect of Cocaine on Extracellular Dopamine in the Nucleus Accumbens: a Dual Core-Shell Voltammetry Study in Anesthetized Rats , 2008, Sensors.

[84]  A. Meyer-Lindenberg,et al.  5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression , 2005, Nature Neuroscience.

[85]  Karl J. Friston,et al.  Statistical parametric mapping , 2013 .

[86]  J. Kauer Neuroscience: A home for the nicotine habit , 2005, Nature.

[87]  J. Hagan,et al.  1,2,4-Triazol-3-yl-thiopropyl-tetrahydrobenzazepines: A Series of Potent and Selective Dopamine D3 Receptor Antagonists , 2007 .

[88]  Angelo Mosso,et al.  Ueber den Kreislauf des Blutes im menschlichen Gehirn , 1881 .

[89]  Clara A. Scholl,et al.  Synchronized delta oscillations correlate with the resting-state functional MRI signal , 2007, Proceedings of the National Academy of Sciences.

[90]  Angelo Bifone,et al.  Antagonism at serotonin 5-HT2A receptors modulates functional activity of frontohippocampal circuit , 2010, Psychopharmacology.

[91]  Brian Everitt,et al.  Cluster analysis , 1974 .

[92]  J. Swanson,et al.  Dopamine in drug abuse and addiction: results of imaging studies and treatment implications. , 2007, Archives of neurology.

[93]  O. Sporns,et al.  Complex brain networks: graph theoretical analysis of structural and functional systems , 2009, Nature Reviews Neuroscience.

[94]  L. Cervo,et al.  Selective antagonism at dopamine D3 receptors attenuates cocaine-seeking behaviour in the rat. , 2007, The international journal of neuropsychopharmacology.

[95]  B R Rosen,et al.  Detection of the effects of dopamine receptor supersensitivity using pharmacological MRI and correlations with PET , 2000, Synapse.

[96]  G. Cecchi,et al.  Scale-free brain functional networks. , 2003, Physical review letters.

[97]  R. S. Hinks,et al.  Time course EPI of human brain function during task activation , 1992, Magnetic resonance in medicine.

[98]  Karl J. Friston,et al.  Functional Connectivity: The Principal-Component Analysis of Large (PET) Data Sets , 1993, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[99]  E. Bullmore,et al.  Undirected graphs of frequency-dependent functional connectivity in whole brain networks , 2005, Philosophical Transactions of the Royal Society B: Biological Sciences.

[100]  Seth R. Jones,et al.  Resting‐state functional connectivity of the rat brain , 2008, Magnetic resonance in medicine.

[101]  C. Sherrington,et al.  On the Regulation of the Blood‐supply of the Brain , 1890, The Journal of physiology.

[102]  Renate Thienel,et al.  Functional brain imaging of symptoms and cognition in schizophrenia. , 2005, Progress in brain research.

[103]  R. Turner,et al.  Dynamic magnetic resonance imaging of human brain activity during primary sensory stimulation. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[104]  Barry Horwitz,et al.  The elusive concept of brain connectivity , 2003, NeuroImage.

[105]  E. Levin,et al.  Nicotinic acetylcholine involvement in cognitive function in animals , 1998, Psychopharmacology.

[106]  Angelo Bifone,et al.  A stereotaxic MRI template set for the rat brain with tissue class distribution maps and co-registered anatomical atlas: Application to pharmacological MRI , 2006, NeuroImage.

[107]  T. Reese,et al.  Functional MRI using intravascular contrast agents: detrending of the relative cerebrovascular (rCBV) time course. , 2003, Magnetic resonance imaging.

[108]  M E J Newman,et al.  Finding and evaluating community structure in networks. , 2003, Physical review. E, Statistical, nonlinear, and soft matter physics.

[109]  John C. Gore,et al.  Changes in rat cerebral blood volume due to modulation of the 5-HT1A receptor measured with susceptibility enhanced contrast MRI , 2001, Brain Research.

[110]  E. Levin,et al.  Nicotinic treatment for cognitive dysfunction. , 2002, Current drug targets. CNS and neurological disorders.

[111]  Michel Modo,et al.  A pharmacological MRI assessment of dizocilpine (MK-801) in the 3-nitroproprionic acid-lesioned rat , 2008, Neuroscience Letters.

[112]  P. Flecknell Laboratory animal anaesthesia : an introduction for research workers and technicians , 1987 .

[113]  Vinod Menon,et al.  Functional connectivity in the resting brain: A network analysis of the default mode hypothesis , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[114]  Timo Kurki,et al.  Effects of Subanesthetic Doses of Ketamine on Regional Cerebral Blood Flow, Oxygen Consumption, and Blood Volume in Humans , 2003, Anesthesiology.

[115]  N. Bruggen,et al.  Biomedical Imaging in Experimental Neuroscience , 2002 .

[116]  Angelo Bifone,et al.  Study-level wavelet cluster analysis and data-driven signal models in pharmacological MRI , 2007, Journal of Neuroscience Methods.

[117]  Raffael Kalisch,et al.  High trait anxiety and hyporeactivity to stress of the dorsomedial prefrontal cortex: a combined phMRI and Fos study in rats , 2004, NeuroImage.

[118]  S. Strogatz Exploring complex networks , 2001, Nature.

[119]  John Suckling,et al.  Attenuation of the neural response to sad faces in major depression by antidepressant treatment: a prospective, event-related functional magnetic resonance imaging study. , 2004, Archives of general psychiatry.

[120]  B. Rosen,et al.  Cocaine Activation Discriminates Dopaminergic Projections by Temporal Response: An fMRI Study in Rat , 2000, NeuroImage.

[121]  Richard S. J. Frackowiak,et al.  A functional neuroanatomy of hallucinations in schizophrenia , 1995, Nature.

[122]  Angelo Bifone,et al.  Region-Specific Effects of Nicotine on Brain Activity: A Pharmacological MRI Study in the Drug-Naïve Rat , 2006, Neuropsychopharmacology.

[123]  Society of magnetic resonance in medicine , 1990 .

[124]  F. Luo,et al.  Characterization of effects of mean arterial blood pressure induced by cocaine and cocaine methiodide on BOLD signals in rat brain , 2003, Magnetic resonance in medicine.

[125]  R. Mailman,et al.  Differential effects of clozapine and haloperidol on ketamine-induced brain metabolic activation , 1998, Brain Research.

[126]  Gaohong Wu,et al.  Opiate tolerance by heroin self‐administration: An fMRI study in rat , 2004, Magnetic resonance in medicine.

[127]  M. Fukunaga,et al.  Low frequency BOLD fluctuations during resting wakefulness and light sleep: A simultaneous EEG‐fMRI study , 2008, Human brain mapping.

[128]  Steven C. R. Williams,et al.  Using the BOLD MR signal to differentiate the stereoisomers of ketamine in the rat , 2006, NeuroImage.

[129]  Angelo Bifone,et al.  Concurrent pharmacological MRI and in situ microdialysis of cocaine reveal a complex relationship between the central hemodynamic response and local dopamine concentration , 2004, NeuroImage.

[130]  Angelo Bifone,et al.  A Neural Switch for Active and Passive Fear , 2012, Neuron.

[131]  Jason W. Brown,et al.  Correlations between glucose metabolic rates in brain regions of healthy male adults at rest and during language stimulation , 1987, Brain and Language.

[132]  Angelo Bifone,et al.  Differential Effects of Antipsychotic and Glutamatergic Agents on the phMRI Response to Phencyclidine , 2008, Neuropsychopharmacology.

[133]  P. Liddle,et al.  Immediate effects of risperidone on cortico–striato–thalamic loops and the hippocampus , 2000, British Journal of Psychiatry.

[134]  F. Sharp,et al.  Effects of phencyclidine on immediate early gene expression in the brain , 1996, Journal of neuroscience research.

[135]  J. Meador-Woodruff,et al.  Thalamic dysfunction in schizophrenia: neurochemical, neuropathological, and in vivo imaging abnormalities , 2004, Schizophrenia Research.

[136]  I. Gottesman,et al.  The endophenotype concept in psychiatry: etymology and strategic intentions. , 2003, The American journal of psychiatry.

[137]  D. Cyril D’Souza,et al.  Interactive effects of subanesthetic ketamine and haloperidol in healthy humans , 1999, Psychopharmacology.

[138]  Bharat B. Biswal,et al.  A protocol for use of medetomidine anesthesia in rats for extended studies using task-induced BOLD contrast and resting-state functional connectivity , 2009, NeuroImage.

[139]  C. Large,et al.  Do NMDA receptor antagonist models of schizophrenia predict the clinical efficacy of antipsychotic drugs? , 2007, Journal of psychopharmacology.

[140]  Waqas Majeed,et al.  Spatiotemporal dynamics of low frequency fluctuations in BOLD fMRI of the rat , 2009, Journal of magnetic resonance imaging : JMRI.

[141]  J. Meador-Woodruff,et al.  NMDA receptors and schizophrenia. , 2007, Current opinion in pharmacology.

[142]  Karl J. Friston,et al.  Human Brain Function , 1997 .

[143]  Angelo Bifone,et al.  Selective dopamine D3 receptor antagonist SB‐277011‐A potentiates phMRI response to acute amphetamine challenge in the rat brain , 2004, Synapse.

[144]  A. Catafau,et al.  Prefrontal dysfunction in young acute neuroleptic-naive schizophrenic patients: A resting and activation SPECT study , 1994, Psychiatry Research: Neuroimaging.

[145]  J. Hagan,et al.  The role of central dopamine D3 receptors in drug addiction: a review of pharmacological evidence , 2005, Brain Research Reviews.

[146]  J. Mazziotta,et al.  Brain Mapping: The Methods , 2002 .

[147]  T. Reese,et al.  Regional brain activation by bicuculline visualized by functional magnetic resonance imaging. Time‐resolved assessment of bicuculline‐induced changes in local cerebral blood volume using an intravascular contrast agent , 1995, NMR in biomedicine.

[148]  Timothy Q. Duong,et al.  Hemodynamic and metabolic changes induced by cocaine in anesthetized rat observed with multimodal functional MRI , 2006, Psychopharmacology.

[149]  Gaohong Wu,et al.  Alzheimer Disease: evaluation of a functional MR imaging index as a marker. , 2002, Radiology.

[150]  Steven C. R. Williams,et al.  Functional magnetic resonance imaging and c-Fos mapping in rats following an anorectic dose of m-chlorophenylpiperazine , 2006, NeuroImage.

[151]  Lei Zhou,et al.  BOLD study of stimulation-induced neural activity and resting-state connectivity in medetomidine-sedated rat , 2008, NeuroImage.

[152]  Brian Knutson,et al.  Linking nucleus accumbens dopamine and blood oxygenation , 2007, Psychopharmacology.